ARCHIVES

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

This article is from The Cancer Letter archive.

Vol. 35 No. 02 | January 16, 2009

Download PDF Visit The Full Archive

Related Articles

Five Proposals Submitted In Recompetition Of FCRF Operations/Support Contract; Now Under Review

January 2, 1987

NCI Toughens Criteria for MERIT Awards

February 23, 1996

MIT’s Sharp To Head Biology Dept.; Hynes To Head Cancer Center

April 12, 1991

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

September 28, 2012

Medicare: Clinton Budget Revives Proposal To End Physician Drug Markup

February 6, 1998

FDA Publishes Two Guidances for Lab-Developed Tests

October 3, 2014